Literature DB >> 15175864

Lack of association of polymorphisms of the lymphotoxin alpha gene with myocardial infarction in Japanese.

Akira Yamada1, Sahoko Ichihara, Yosuke Murase, Tomoko Kato, Hideo Izawa, Kohzo Nagata, Toyoaki Murohara, Yoshiji Yamada, Mitsuhiro Yokota.   

Abstract

Vascular inflammation plays an important role in the development of myocardial infarction (MI). Lymphotoxin alpha (LTA) is a cytokine with multiple functions in regulation of the immune system and inflammatory reactions. The aim of this study was to examine whether polymorphisms of the LTA gene are associated with the risk of MI in Japanese men and women. A case-control association study was performed for the 252A-->G and 804C-->A polymorphisms of the LTA gene and the prevalence of MI. The study population comprised 3,689 unrelated Japanese individuals (2,486 men, 1,203 women), including 1891 patients with MI (1,493 men, 398 women) and 1798 control subjects (993 men, 805 women). Among the control subjects 257 individuals (108 men, 149 women) who had none of the conventional risk factors for coronary artery disease (CAD) were defined as low-risk controls. Genotypes for the two polymorphisms were determined with a fluorescence-based allele-specific DNA primer assay system. Among all study subjects the 252A-->G and 804C-->A polymorphisms exhibited linkage disequilibrium. No association of either polymorphism with MI was detected in men or in women in comparisons with total control or low-risk control subjects. However, each of the two polymorphisms was associated with the prevalence of type 2 diabetes mellitus both in men with MI and in those without MI in a recessive genetic model. No association was detected between the polymorphisms and other conventional risk factors for CAD. The LTA gene thus does not appear to be a susceptibility locus for MI in Japanese men or women, although it might affect susceptibility to type 2 diabetes in Japanese men.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15175864     DOI: 10.1007/s00109-004-0556-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  23 in total

1.  Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis.

Authors:  D H McDermott; J P Halcox; W H Schenke; M A Waclawiw; M N Merrell; N Epstein; A A Quyyumi; P M Murphy
Journal:  Circ Res       Date:  2001-08-31       Impact factor: 17.367

2.  Risk of myocardial infarction and polymorphisms in candidate genes.

Authors:  Pier M Mannucci; Flora Peyvandi; Diego Ardissino
Journal:  N Engl J Med       Date:  2003-03-20       Impact factor: 91.245

3.  ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study.

Authors:  B Agerholm-Larsen; B G Nordestgaard; R Steffensen; T I Sørensen; G Jensen; A Tybjaerg-Hansen
Journal:  Circulation       Date:  1997-05-20       Impact factor: 29.690

4.  Detection and localization of tumor necrosis factor in human atheroma.

Authors:  P Barath; M C Fishbein; J Cao; J Berenson; R H Helfant; J S Forrester
Journal:  Am J Cardiol       Date:  1990-02-01       Impact factor: 2.778

5.  Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction.

Authors:  Kouichi Ozaki; Yozo Ohnishi; Aritoshi Iida; Akihiko Sekine; Ryo Yamada; Tatsuhiko Tsunoda; Hiroshi Sato; Hideyuki Sato; Masatsugu Hori; Yusuke Nakamura; Toshihiro Tanaka
Journal:  Nat Genet       Date:  2002-11-11       Impact factor: 38.330

6.  Tumour necrosis factor beta alleles and hyperinsulinaemia in coronary artery disease.

Authors:  J Braun; W März; B R Winkelmann; H Donner; K Henning Usadel; K Badenhoop
Journal:  Eur J Clin Invest       Date:  1998-07       Impact factor: 4.686

7.  Toll-like receptor 4 polymorphisms and atherogenesis.

Authors:  Stefan Kiechl; Eva Lorenz; Markus Reindl; Christian J Wiedermann; Friedrich Oberhollenzer; Enzo Bonora; Johann Willeit; David A Schwartz
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

8.  Polymorphism Ncol in tumor necrosis factor B is associated with fasting glycemia and lipid parameters in healthy non-obese caucasian subjects.

Authors:  K Kanková; I Márová; E H J M Jansen; A Vasků; M Jurajda; J Vácha
Journal:  Diabetes Metab       Date:  2002-06       Impact factor: 6.041

9.  Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting.

Authors:  Werner Koch; Klaus Tiroch; Nicolas von Beckerath; Albert Schömig; Adnan Kastrati
Journal:  Cytokine       Date:  2003-11-21       Impact factor: 3.861

10.  Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production.

Authors:  G Messer; U Spengler; M C Jung; G Honold; K Blömer; G R Pape; G Riethmüller; E H Weiss
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

View more
  21 in total

Review 1.  Genome-wide association studies: progress and potential for drug discovery and development.

Authors:  Stephen F Kingsmore; Ingrid E Lindquist; Joann Mudge; Damian D Gessler; William D Beavis
Journal:  Nat Rev Drug Discov       Date:  2008-03       Impact factor: 84.694

Review 2.  Advances in the genetic basis of coronary artery disease.

Authors:  Qing Wang
Journal:  Curr Atheroscler Rep       Date:  2005-05       Impact factor: 5.113

Review 3.  Linking the microbiota and metabolic disease with lymphotoxin.

Authors:  Vaibhav Upadhyay; Yang-Xin Fu
Journal:  Int Immunol       Date:  2013-05-08       Impact factor: 4.823

4.  The common T60N polymorphism of the lymphotoxin-alpha gene is associated with type 2 diabetes and other phenotypes of the metabolic syndrome.

Authors:  Y H Hamid; S A Urhammer; C Glümer; K Borch-Johnsen; T Jørgensen; T Hansen; O Pedersen
Journal:  Diabetologia       Date:  2005-02-24       Impact factor: 10.122

Review 5.  Nonconventional genetic risk factors for cardiovascular disease.

Authors:  Christopher N Tymchuk; Jaana Hartiala; Pragna I Patel; Margarete Mehrabian; Hooman Allayee
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

Review 6.  Lymphotoxin organizes contributions to host defense and metabolic illness from innate lymphoid cells.

Authors:  Vaibhav Upadhyay; Yang-Xin Fu
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-24       Impact factor: 7.638

Review 7.  Inflammation as a risk factor for myocardial infarction.

Authors:  Toshihiro Tanaka; Kouichi Ozaki
Journal:  J Hum Genet       Date:  2006-06-13       Impact factor: 3.172

8.  Large-scale association analysis of TNF/LTA gene region polymorphisms in type 2 diabetes.

Authors:  Vesna Boraska; Nigel W Rayner; Christopher J Groves; Timothy M Frayling; Mahamadou Diakite; Kirk A Rockett; Dominic P Kwiatkowski; Aaron G Day-Williams; Mark I McCarthy; Eleftheria Zeggini
Journal:  BMC Med Genet       Date:  2010-05-06       Impact factor: 2.103

9.  Genome-wide association studies: progress in identifying genetic biomarkers in common, complex diseases.

Authors:  Stephen F Kingsmore; Ingrid E Lindquist; Joann Mudge; William D Beavis
Journal:  Biomark Insights       Date:  2007-08-08

10.  Lymphotoxin-alpha and galectin-2 SNPs are not associated with myocardial infarction in two different German populations.

Authors:  Kamil Sedlacek; Katharina Neureuther; Jakob C Mueller; Klaus Stark; Marcus Fischer; Andrea Baessler; Wibke Reinhard; Ulrich Broeckel; Wolfgang Lieb; Jeanette Erdmann; Heribert Schunkert; Günter Riegger; Thomas Illig; Thomas Meitinger; Christian Hengstenberg
Journal:  J Mol Med (Berl)       Date:  2007-05-12       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.